Direxion Daily S&P Biotech Bear 3X Shares Technicals
Direxion Daily S&P Biotech Bear 3X Shares logo

Direxion Daily S&P Biotech Bear 3X Shares(ALLUS_LABD)

$14.05-2.36%

Market is closed - opens 7 PM, 30 May 2023

Insights

  • Direxion Daily S&P Biotech Bear 3X Shares is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Direxion Daily S&P Biotech Bear 3X Shares stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Direxion Daily S&P Biotech Bear 3X Shares stock is in a downtrend↘️
  • Based on analysis of the Pivot Points, the current market trend for Direxion Daily S&P Biotech Bear 3X Shares stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
45.49
Neutral
Stochastic
36.28, 25.91
Neutral
Ultimate Oscillator
50.16
Neutral
Stochastic Relative Strength Index
94.73, 78.61
Neutral
Moving Average Convergence Divergence
-0.92, -1.16
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
13.42
Sell
20
13.81
Sell
50
17.26
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
13.65
Sell
20
14.21
Sell
50
15.8
Sell

Volume Weighted Moving Average

Period (Days)

Value

Action

10
13.33
Buy
20
13.78
Neutral
50
16.43
Sell

Double Exponential Moving Average

Period (Days)

Value

Action

10
13.44
Buy
20
12.86
Sell
50
14.14
Sell

Triple Exponential Moving Average

Period (Days)

Value

Action

10
13.89
Buy
20
12.94
Sell
50
13.19
Sell

Pivot

Pivot

Value

Resistance L3
15.25
Resistance L2
14.96
Resistance L1
14.5
Pivot Point
14.21
Support L1
13.75
Support L2
13.46
Support L3
13.0

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.